The IFN–glycolysis axis as identified by our study is also relevant in the antiproliferative impact of IFN as recently highlighted by the reduction of the metabolic glycolytic response of murine bone marrow-derived macrophages to infection with Mycobacterium tuberculosis after application of IFN β (Olson et al., 2021). The gene discussed is IFNA1; the disease is infection.